Switch to:
Medtronic, Inc. (NYSE:MDT)
Research and Development
$1,501 Mil (TTM As of Jan. 2014)

This is the expense the company spent on research and development. Medtronic, Inc.'s research and development for the three months ended in Jan. 2014 was $360 Mil. Its research and development for the trailing twelve months (TTM) ended in Jan. 2014 was $1,501 Mil.


Definition

This is the expense the company spent on research and development.

Medtronic, Inc. Research & Development for the trailing twelve months (TTM) ended in Jan. 2014 was 409 (Apr. 2013 ) + 360 (Jul. 2013 ) + 372 (Oct. 2013 ) + 360 (Jan. 2014 ) = $1,501 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Medtronic, Inc. Annual Data

Apr04Apr05Apr06Apr07Apr08Apr09Apr10Apr11Apr12Apr13
Research & Development 8529511,1131,2391,2751,3551,4601,4721,4901,557

Medtronic, Inc. Quarterly Data

Oct11Jan12Apr12Jul12Oct12Jan13Apr13Jul13Oct13Jan14
Research & Development 371364393385387376409360372360
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide